The call Disrupting drug resistance using innovative design has been launched within the framework of the ERA-NET JPIAMR-ACTION and will involve 26 funding organisations from 17 countries. The total estimated call budget is 17 million Euro.
Proposals should focus on licenced antimicrobial agents (antibiotics/antifungals) or agents under pre-clinical and/or early clinical development.
Webinar for applicants: JPIAMR is pleased to invite researchers to a live webinar on the 25th of January 2022 presenting the call and the partner search tool. Representatives from funders participating in the call will be available to answer questions.